mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K30748066 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.6 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
HBX-41108 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
KU-55933 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K33514849 |
CTRPv2 |
pan-cancer |
AAC |
-0.053 |
0.6 |
mRNA |
necrostatin-1 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-A94377914 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |